Membranous Nephropathy: Approaches to Treatment

American Journal of Nephrology
Andrew S Bomback, Fernando C Fervenza

Abstract

Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. This review focuses on mechanisms involved in the pathogenesis of MN and approaches to treatment of this disease. Our understanding of the pathogenesis of primary MN has advanced greatly with the identification of M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A as target antigens whose antibodies serve as biomarkers of this disease. Additional research, including investigations into the roles of complement and melanocortin receptors on the podocyte, may further improve our understanding of how best to treat this condition. Immunosuppressive therapies, including corticosteroids alternating with alkylating agents, and calcineurin inhibitors are partially successful in reducing proteinuria in MN, but their use may be associated with significant adverse effects and a high relapse rate. Novel interventions, including targeting B cells with rituximab as well as treatment with adrenocorticotropic hormone (ACTH), are being investigated. Key Messages: The understanding of treatment targets and availability of new biomarkers has facilitated diagnosis and improved risk stratification for MN and may also be useful for individualiz...Continue Reading

Citations

Nov 19, 2019·Expert Opinion on Drug Discovery·Adrián M RamosAlberto Ortiz
Dec 15, 2018·Human Vaccines & Immunotherapeutics·Mary Helen Foster, Jeffrey Robinson Ord
Jun 7, 2019·F1000Research·Shin'ichi AkiyamaShoichi Maruyama
Apr 22, 2020·Proceedings·Stephen TannerArundhati Rao
Mar 8, 2019·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Aydilek Dagdeviren CakirOlcay Evliyaoglu
Mar 8, 2019·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Aydilek Dagdeviren CakirOlcay Evliyaoglu
Sep 18, 2018·Molecular Medicine Reports·Amir TaherkhaniKoorosh Tabar
Jul 1, 2020·Cytometry. Part B, Clinical Cytometry·Arianna GattiBruno Brando
Mar 7, 2021·BMJ Case Reports·Gabriela F SantosAlice M Turner
Apr 4, 2021·Journal of Clinical Medicine·Barbara MoszczukKrzysztof Mucha
Apr 15, 2021·Clinical Journal of the American Society of Nephrology : CJASN·Guoqin WangHong Cheng
Apr 17, 2021·Life Sciences·Rahim IranzadMehdi Yousefi
Jul 11, 2021·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Maurizio Salvadori, Aris Tsalouchos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Related Papers

Nature Reviews. Nephrology
Piero RuggenentiGiuseppe Remuzzi
Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
Rivka Ayalon, Laurence H Beck
© 2022 Meta ULC. All rights reserved